Mahindra Manulife Mid Cap Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.38%)Nav, as on 06-02-2026

  • Previous Nav

  • Net Change on 06-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to seek to generate long term capital appreciation &provide long-term growth opportunities by investing in a portfolio constituted of equity & equityrelated securities and derivatives predominantly in mid cap companies. However, there can be noassurance that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mahindra Manulife Mid Cap Fund - Regular Plan - Growth -3.10 0.03 8.31 24.14 21.85 16.20
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Midcap 150 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mahindra Manulife Mid Cap Fund - Regular Plan - Growth Jan 30, 2018 8.31 24.14 21.85 1.84 4,267.43
Nippon India Growth Mid Cap Fund-Growth Plan-Growth Option Oct 08, 1995 12.60 25.74 22.95 1.54 41,727.36
HSBC Midcap Fund - Regular Growth Aug 09, 2004 14.35 25.00 19.59 1.72 12,175.46
UTI Mid Cap Fund-Growth Option Jul 30, 2005 Unrated 6.09 16.94 16.15 1.76 11,492.83
Quant Mid Cap Fund-Growth Feb 26, 2001 -6.06 14.64 20.00 1.80 7,283.39
LIC MF Mid Cap Fund-Regular Plan-Growth Jan 25, 2017 3.55 20.48 15.76 2.50 330.68

Fund Holdings as on 31-January-2026

  • Glenmark Pharmaceuticals Limited

  • The Federal Bank Limited

  • Piramal Finance Limited

  • Union Bank of India

  • IndusInd Bank Limited

  • Indus Towers Limited

  • Max Financial Services Limited

  • IDFC First Bank Limited

  • AIA Engineering Limited

  • Indian Bank

  • JK Cement Limited

  • Blue Star Limited

  • JSW Energy Limited

  • UNO Minda Limited

  • Nippon Life India Asset Management Limited

  • Net Receivables / (Payables)

  • Astral Limited

  • KEI Industries Limited

  • L&T Finance Limited

  • MphasiS Limited

  • Marico Limited

  • Bharat Heavy Electricals Limited

  • APL Apollo Tubes Limited

  • Tube Investments Of India Limited

  • Alkem Laboratories Limited

  • Coforge Limited

  • Oil India Limited

  • Anthem Biosciences Limited

  • NMDC Limited

  • Shriram Finance Limited

  • Bharti Hexacom Limited

  • Aditya Birla Capital Limited

  • Bank of Maharashtra

  • JSW Infrastructure Ltd

  • Varun Beverages Ltd

  • Biocon Limited

  • Triveni Turbine Limited

  • SRF Limited

  • Lupin Limited

  • Equitas Small Finance Bank Limited

  • Hexaware Technologies Limited

  • Solar Industries India Limited

  • ITC Hotels Limited

  • Godrej Properties Limited

  • Persistent Systems Ltd

  • Fortis Healthcare Limited

  • Dalmia Bharat Limited

  • Aster DM Healthcare Limited

  • LIC Housing Finance Limited

  • Schaeffler India Limited

  • Radico Khaitan Limited

  • Torrent Power Limited

  • Belrise Industries Ltd.

  • Kajaria Ceramics Limited

  • Kirloskar Brothers Limited

  • Minda Corporation Limited

  • CEAT Limited

  • LG Electronics India Ltd

  • Atul Limited

  • Sri Lotus Developers and Realty Ltd.

  • Havells India Limited

  • Whirlpool of India Limited

View More

  • Bank - Private

  • Pharmaceuticals & Drugs

  • Bank - Public

  • IT - Software

  • Auto Ancillary

  • Finance - NBFC

  • Telecommunication - Service Provider

  • Finance - Housing

  • Cement & Construction Materials

  • Chemicals

  • Power Generation/Distribution

  • Engineering - Industrial Equipments

  • Finance - Others

  • Castings/Forgings

  • Air Conditioners

  • Hospital & Healthcare Services

  • Finance - Asset Management

  • Plastic Products

  • Miscellaneous

  • Cable

  • Construction - Real Estate

  • Edible Oil

  • Steel & Iron Products

  • Oil Exploration

  • Mining & Minerals

  • Port

  • Consumer Durables - Domestic Appliances

  • Consumer Food

  • Hotel, Resort & Restaurants

  • Bearings

  • Breweries & Distilleries

  • Ceramics/Marble/Granite/Sanitaryware

  • Compressors / Pumps

  • Tyres & Allied

  • Electric Equipment

View More

Fund Manager

  • Cash

  • Equity

View More

About Mahindra Manulife Mid Cap Fund

Scheme Analysis

Mahindra Manulife Mid Cap Fund is a Equity - Mid Cap Fund fund and belongs to Mahindra Manulife Mutual Fund. It was launched on 30-Jan-2018 and currently has an AUM of ₹4,267.43 crore. Mahindra Manulife Mid Cap Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Midcap 150 - TRI as secondary index.

The NAV of Mahindra Manulife Mid Cap Fund ended down ₹-0.13(-0.38%)yesterday to ₹33.3661.

Among its top 3 holdings the fund has exposure to Glenmark Pharmaceuticals Limited, and

The Mahindra Manulife Mid Cap Fund is managed by Krishna Sanghavi and Manish Lodha.

Fund House Contact

Unit No. 204, 2nd Floor, Amiti Building Piramal Agastya Corporate Park, LBS Road, Kamani Junction, Kurla (W) Mumbai - 400070

022-66327900